Medications

COVID-19: Physician co-authors analysis of antiviral drug

In a small group of patients hospitalized with severe complications of COVID-19 and treated with the experimental antiviral drug remdesivir, clinical improvement was observed in 68% of patients treated, according to an analysis ...

Oncology & Cancer

Certain factors linked with discontinuing breast cancer therapy

For women with hormone receptor-positive breast cancer, long-term endocrine therapy can greatly reduce the risk of recurrence. Many women, especially those in underserved populations, do not continue treatment, however. A ...

page 30 from 40